ACTISONO
Ideally, drug treatments should be designed to be as precise and controllable as possible in order to administer the active ingredients at the site of action in the body. This requires new technologies, such as the control of bioactive substances “from a distance”. This is where the Leibniz ScienceCampus “ACTISONO” comes in. The researchers' aim is to use ultrasound to control the activity of drugs and therapeutically active nucleic acids.
Treating patients with pharmaceuticals is one of the most important and frequently used medical therapies available to us. However, their use is often a compromise between desired treatment and undesirable side effects. The associated disadvantages often have to be accepted due to the limited possibilities of only delivering the active ingredients to the necessary location in the body.
It is therefore all the more important that drug treatments are designed to be as precise and controllable as possible in order to administer the active ingredients at the site of action in the body. This requires new technologies, such as the control of bioactive substances “from a distance”.
This is precisely where the Leibniz ScienceCampus “ACTISONO” (Sonopharmacology - Activation of Drugs by Ultrasound) comes in. The aim is to use ultrasound to control the activity of drugs and therapeutically active nucleic acids. An interdisciplinary team of researchers from the fields of polymer chemistry, medicine, biology and engineering work together on various scientific and methodological projects.
Among other things, they are developing so-called microbubbles for the activation of antibiotics using ultrasound or researching how the regeneration of the liver after an operation can be improved using ultrasound. Their aim is to revolutionize the activation of active substances deep in the body and establish the research field of “sonopharmacology”.
Spoke Person and Coordination
